Description
EMPAFLO M Tablets 12.5mg + 1000mg (30’s pack) combine Empagliflozin and Metformin to provide effective management of type 2 diabetes mellitus. Each tablet contains 12.5mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose excretion via the kidneys, and 1000mg of Metformin, which reduces hepatic glucose production and improves insulin sensitivity.
This combination helps improve blood sugar control, supports weight management, and may offer cardiovascular benefits. The 30-tablet pack ensures a convenient supply for ongoing treatment.
Manufactured under strict quality controls, EMPAFLO M Tablets guarantee safety, efficacy, and consistent therapeutic outcomes. Patients should follow their healthcare provider’s instructions and incorporate lifestyle changes such as a healthy diet and regular exercise to optimize treatment results.
Reviews
There are no reviews yet.